Ten entrepreneurial life science and technology businesses have begun the immersive Discovery Spark programme, with a prize package worth over £50,000 up for grabs.
These will be used to package a medication indicated for the prophylaxis and treatment of seasonal and perennial allergic rhinitis, as well as vasomotor rhinitis.
University of Birmingham Enterprise announces the launch of Biocell Energetics, to provide profiling and testing services that assess, in real-time, how living cells produce energy.
ProductLife Group announced the acquisition of Halloran Consulting Group, uniting both companies under a commitment to provide safe and effective healthcare solutions across the globe.
Patients receiving treatment for bowel cancer at Sheffield Teaching Hospitals NHS Foundation Trust will have the chance to try personalised 'vaccines' thanks to the launch of a NHS “matchmaking” service.
Johnson & Johnson (J&J) has announced that it has taken over all sales, marketing, and distribution responsibilities for Remicade (infliximab) and Simponi (golimumab) in the UK.
